Literature DB >> 12049469

Milestones of helmintic research at Bayer.

A Harder1.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 12049469     DOI: 10.1007/s00436-001-0551-x

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


× No keyword cloud information.
  5 in total

Review 1.  Schistosomiasis--a century searching for chemotherapeutic drugs.

Authors:  Gabriela Ribeiro-dos-Santos; Sergio Verjovski-Almeida; Luciana C C Leite
Journal:  Parasitol Res       Date:  2006-04-25       Impact factor: 2.289

2.  Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening.

Authors:  Maha-Hamadien Abdulla; Debbie S Ruelas; Brian Wolff; June Snedecor; Kee-Chong Lim; Fengyun Xu; Adam R Renslo; Janice Williams; James H McKerrow; Conor R Caffrey
Journal:  PLoS Negl Trop Dis       Date:  2009-07-14

3.  Potential drug development candidates for human soil-transmitted helminthiases.

Authors:  Piero Olliaro; Jürg Seiler; Annette Kuesel; John Horton; Jeffrey N Clark; Robert Don; Jennifer Keiser
Journal:  PLoS Negl Trop Dis       Date:  2011-06-07

Review 4.  Activation of transient receptor potential channel Sm.(Schistosoma mansoni)TRPMPZQ by PZQ, enhanced Ca++ influx, spastic paralysis, and tegumental disrupture-the deadly cascade in parasitic schistosomes, other trematodes, and cestodes.

Authors:  Achim Harder
Journal:  Parasitol Res       Date:  2020-06-30       Impact factor: 2.289

Review 5.  Development of emodepside as a possible adulticidal treatment for human onchocerciasis-The fruit of a successful industrial-academic collaboration.

Authors:  Jürgen Krücken; Lindy Holden-Dye; Jennifer Keiser; Roger K Prichard; Simon Townson; Benjamin L Makepeace; Marc P Hübner; Steffen R Hahnel; Ivan Scandale; Achim Harder; Daniel Kulke
Journal:  PLoS Pathog       Date:  2021-07-22       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.